Current Neuro-Oncology
Volume
23 Number 6
31 March 2021
Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 6, 31 March
Tepe
M, Saylisoy S, Toprak U, Inan I.
The
Potential Role of Peritumoral Apparent Diffusion Coefficient
Evaluation in Differentiating Glioblastoma and Solitary Metastatic
Lesions of the Brain.
Curr
Med Imaging. 2021 Mar 16∟.
doi: 10.2174/1573405617666210316120314∟.
PMID: 33726654∟.
Observational study. ˍ
*
Xi
J, Hassan B, Katumba RGN, Khaddour K, Govindan A, Luo J, Huang J,
Campian JL.
The
predictive value of absolute lymphocyte counts on tumor
progression and pseudoprogression in patients with
glioblastoma.
BMC
Cancer. 2021 Mar 16, 2021;21(1):285∟.
doi: 10.1186/s12885-021-08004-2∟.
PMID: 33726710∟.
Observational study. ˍ
Gupta
M, Burns E, Georgantas NZ, Thierauf J, Nayyar N, Gordon A, Jones
S, Pisapia M, Sun Y, Burns RP, Velarde JK, Jordan JT, Frigault MJ,
Nahed BV, Jones PS, Barker FG, Curry W, Gupta R, Batchelor TT,
Romero J, Brastianos P, Marble H, Martinez-Lage M, Tateishi K,
Lennerz JK, Dietrich J, Cahill D, Carter B, Shankar GM.
A
Rapid Genotyping Panel for Detection of Primary Central Nervous
System Lymphoma.
Blood.
2021 Mar 18, 2021:blood.202001013∟.
doi: 10.1182/blood.2020010137∟.
PMID: 33735913∟.
Observational study. ˍ
Shin
I, Kim H, Ahn SS, Sohn B, Bae S, Park JE, Kim HS, Lee
SK.
Development
and Validation of a Deep Learning-Based Model to Distinguish
Glioblastoma from Solitary Brain Metastasis Using Conventional MR
Images.
AJNR
Am J Neuroradiol. 2021 Mar 18∟.
doi: 10.3174/ajnr.A7003∟.
PMID: 33737268∟.
Observational study. ˍ
Hanania
AN, Paulino AC, Ludmir EB, Shah VS, Su JM, McGovern SL, Baxter PA,
McAleer MF, Grosshans DR, Okcu MF, Chintagumpala MM.
Early
radiotherapy preserves vision in sporadic optic pathway
glioma.
Cancer.
2021 Mar 19∟.
doi: 10.1002/cncr.33497∟.
PMID: 33739455∟.
Observational study. ˍ
Handis
C, Tanrıkulu B, Danyeli AE, Özek MM.
Spinal
intramedullary H3K27M mutant glioma with vertebral metastasis: a
case report.
Childs
Nerv Syst. 2021 Mar 19∟.
doi: 10.1007/s00381-021-05119-6∟.
PMID: 33742289∟.
Case report. ˍ
Skowron
P, Farooq H, Cavalli FMG, Morrissy AS, Ly M, Hendrikse LD, Wang
EY, Djambazian H, Zhu H, Mungall KL, Trinh QM, Zheng T, Dai S,
Stucklin ASG, Vladoiu MC, Fong V, Holgado BL, Nor C, Wu X,
Abd-Rabbo D, Bérubé P, Wang YC, Luu B, Suarez RA,
Rastan A, Gillmor AH, Lee JJY, Zhang XY, Daniels C, Dirks P,
Malkin D, Bouffet E, Tabori U, Loukides J, Doz FP, Bourdeaut F,
Delattre OO, Masliah-Planchon J, Ayrault O, Kim SK, Meyronet D,
Grajkowska WA, Carlotti CG, de Torres C, Mora J, Eberhart CG, Van
Meir EG, Kumabe T, French PJ, Kros JM, Jabado N, Lach B, Pollack
IF, Hamilton RL, Rao AAN, Giannini C, Olson JM, Bognár L,
Klekner A, Zitterbart K, Phillips JJ, Thompson RC, Cooper MK,
Rubin JB, Liau LM, Garami M, Hauser P, Li KKW, Ng HK, Poon WS,
Yancey Gillespie G, Chan JA, Jung S, McLendon RE, Thompson EM,
Zagzag D, Vibhakar R, Ra YS, Garre ML, Schüller U, Shofuda T,
Faria CC, López-Aguilar E, Zadeh G, Hui CC, Ramaswamy V,
Bailey SD, Jones SJ, Mungall AJ, Moore RA, Calarco JA, Stein LD,
Bader GD, Reimand J, Ragoussis J, Weiss WA, Marra MA, Suzuki H,
Taylor MD.
The
transcriptional landscape of Shh medulloblastoma.
Nat
Commun. 2021 Mar 19, 2021;12(1):1749∟.
doi: 10.1038/s41467-021-21883-0∟.
PMID: 33741928∟.
Laboratory investigation. ˍ
Tesileanu
CMS, Vallentgoed WR, Sanson M, Taal W, Clement PM, Wick W, Brandes
AA, Baurain JF, Chinot OL, Wheeler H, Gill S, Griffin M, Rogers L,
Rudà R, Weller M, McBain C, Reijneveld J, Enting RH,
Caparrotti F, Lesimple T, Clenton S, Gijtenbeek A, Lim E, de Vos
F, Mulholland PJ, Taphoorn MJB, de Heer I, Hoogstrate Y, de Wit M,
Boggiani L, Venneker S, Oosting J, Bovée JVMG, Erridge S,
Vogelbaum MA, Nowak AK, Mason WP, Kros JM, Wesseling P, Aldape K,
Jenkins RB, Dubbink HJ, Baumert B, Golfinopoulos V, Gorlia T, van
den Bent M, French PJ.
Non-IDH1-R132H
IDH1/2 mutations are associated with increased DNA methylation and
improved survival in astrocytomas, compared to IDH1-R132H
mutations.
Acta
Neuropathol. 2021 Mar 19∟.
doi: 10.1007/s00401-021-02291-6∟.
PMID: 33740099∟.
Observational study. ˍ
Zima
L, Baine MJ, Sleightholm R, Wang B, Punsoni M, Aizenberg M, Zhang
C.
Pathologic
Characteristics Associated With Local Recurrence of Atypical
Meningiomas Following Surgical Resection.
J
Clin Med Res. 2021 Mar 19, 2021;13(3):143-150∟.
doi: 10.14740/jocmr4444∟.
PMID: 33854653∟.
Observational study. ˍ
*
Fyllingen
EH, Bø LE, Reinertsen I, Jakola AS, Sagberg LM, Berntsen
EM, Salvesen Ø, Solheim O.
Survival
of glioblastoma in relation to tumor location: a statistical tumor
atlas of a population-based cohort.
Acta
Neurochir (Wien). 2021 Mar 20∟.
doi: 10.1007/s00701-021-04802-6∟.
PMID: 33742279∟.
Observational
study.
ˍ
Matsuo
S, Amano T, Miyamatsu Y, Fujioka Y, Nakamizo A.
Neuroimaging
Recommendations in Outpatients With Dementia: Three Cases of
Frontal Meningioma Demonstrating Reversible Dementia.
Cureus.
2021 Mar 21, 2021;13(3):e14028∟.
doi: 10.7759/cureus.14028∟.
PMID: 33889466∟.
Case report. ˍ
Azorín
DD, Winkler F.
Two
routes of direct intercellular communication in brain
cancer.
Biochem
J. 2021 Mar 23, 2021;478(6):1283-1286∟.
doi: 10.1042/BCJ20200990∟.
PMID: 33755120∟.
Comment. ˍ
Refers
to: Pinto
G, et al., Patient-derived glioblastoma stem cells transfer
mitochondria through tunneling nanotubes in tumor
organoids.
Biochem J. 2020 Nov 27, 2021;478(1):21-39∟.
doi: 10.1042/BCJ20200710∟.
PMID: 33245115∟.
Laboratory investigation. ˍ
Goyal-Honavar
A, Chacko G, Chacko AG.
Supratentorial
primary paraganglioma with good long-term outcome following
radical excision.
Br
J Neurosurg. 2021 Mar 23, 2021:1-4∟.
doi: 10.1080/02688697.2021.1902476∟.
PMID: 33754919∟.
Case report. ˍ
Gumrukcu
S, Nguyen TX, White RL, Howell GT, Musikanth P.
Allogeneic
Natural Killer and Cytomegalovirus (CMV)-pp65 Pulsed Dendritic
Cells Induced Complete Response Through 15 Months in a Patient
with Recurrent Glioblastoma: A Case Study.
Am
J Case Rep. 2021 Mar 23, 2021;22:e931030∟.
doi: 10.12659/AJCR.931030∟.
PMID: 33788825∟.
Case report. ˍ
Niesel
K, Schulz M, Anthes J, Alekseeva T, Macas J, Salamero-Boix A,
Möckl A, Oberwahrenbrock T, Lolies M, Stein S, Plate KH,
Reiss Y, Rödel F, Sevenich L.
The
immune suppressive microenvironment affects efficacy of
radio-immunotherapy in brain metastasis.
EMBO
Mol Med. 2021 Mar 23, 2021:e13412∟.
doi: 10.15252/emmm.202013412∟.
PMID: 33755340∟.
Laboratory investigation. ˍ
*
Adhikari
R, Ghose M, Tekin A, Singh S, Singh R.
Intestinal
Perforation: A Rare Complication of Treatment With
Bevacizumab.
Cureus.
2021 Mar 24, 2021;13(3):e14093∟.
doi: 10.7759/cureus.14093∟.
PMID: 33907639∟.
Case report. ˍ
Platten
M, Bunse L, Wick A, Bunse T, Le Cornet L, Harting I, Sahm F,
Sanghvi K, Tan CL, Poschke I, Green E, Justesen S, Behrens GA,
Breckwoldt MO, Freitag A, Rother LM, Schmitt A, Schnell O, Hense
J, Misch M, Krex D, Stevanovic S, Tabatabai G, Steinbach JP,
Bendszus M, von Deimling A, Schmitt M, Wick W.
A
vaccine targeting mutant IDH1 in newly diagnosed glioma.
Nature.
2021 Mar 24,
2021592(7854):463-468∟.
doi: 10.1038/s41586-021-03363-z∟.
PMID: 33762734∟.
Interventional study. ˍ
Lasorella
A, Iavarone A.
The
making of the glioblastoma classification.
Br
J Cancer. 2021 Mar 25∟.
doi: 10.1038/s41416-021-01360-7∟.
PMID: 33767415∟.
Laboratory investigation. ˍ
Liu
Z, Feng S, Li J, Cao H, Huang J, Fan F, Cheng L, Liu Z, Cheng
Q.
The
Survival Benefits of Surgical Resection and Adjuvant Therapy for
Patients With Brainstem Glioma.
Front
Oncol. 2021 Mar 25, 2021;11:566972∟.
doi: 10.3389/fonc.2021.566972∟.
PMID: 33842307∟.
Observational study. ˍ
Williamson
MR, Klug MG, Schwartz GG.
Brain
cancer incidence rates and the presence of nuclear reactors in US
states: a hypothesis-generating study.
Environ
Geochem Health. 2021 Mar 25∟.
doi: 10.1007/s10653-021-00896-0∟.
PMID: 33768349∟.
Observational study. ˍ
Baig
Mirza A, Christodoulides I, Lavrador JP, Giamouriadis A, Vastani
A, Boardman T, Ahmed R, Norman I, Murphy C, Devi S, Vergani F,
Gullan R, Bhangoo R, Ashkan K.
5-Aminolevulinic
acid-guided resection improves the overall survival of patients
with glioblastoma-a comparative cohort study of 343
patients.
Neurooncol
Adv. 2021 Mar 26, 2021;3(1):vdab047∟.
doi: 10.1093/noajnl/vdab047∟.
PMID: 34131646∟.
Observational study. ˍ
Arpa
D, Parisi E, Ghigi G, Cortesi A, Longobardi P, Cenni P, Pieri M,
Tontini L, Neri E, Micheletti S, Ghetti F, Monti M, Foca F, Tesei
A, Arienti C, Sarnelli A, Martinelli G, Romeo A.
Role
of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic
Radiotherapy in Recurrent High-Grade Glioma.
Front
Oncol. 2021 Mar 30, 2021;11:643469∟.
doi: 10.3389/fonc.2021.643469∟.
PMID: 33859944∟.
Interventional study. ˍ
Singla
AK, Madan R, Gupta K, Goyal S, Kumar N, Sahoo SK, Uppal DK, Ahuja
CK.
Clinical
behaviour and outcome in pediatric glioblastoma: current
scenario.
Radiat
Oncol J. 2021 Mar 30, 2021;39(1):72-77∟.
doi: 10.3857/roj.2020.00591∟.
PMID: 33794576∟.
Case report. ˍ
Tabouret
E, Fabbro M, Autran D, Hoang-Xuan K, Taillandier L, Ducray F,
Barrie M, Sanson M, Kerr C, Cartalat-Carel S, Loundou A, Guillevin
R, Mokhtari K, Figarella-Branger D, Delattre JY, Chinot
O.
TEMOBIC:
Phase II Trial of Neoadjuvant Chemotherapy for Unresectable
Anaplastic Gliomas: An ANOCEF Study.
Oncologist.
2021 Mar 30∟.
doi: 10.1002/onco.13765∟.
PMID: 33783067∟.
Interventional study. ˍ
Wu
J, Yuan Y, Long Priel DA, Fink D, Peer CJ, Sissung TM, Su YT, Pang
Y, Yu G, Butler MK, Mendoza TR, Vera E, Ahmad S, Bryla C, Lindsley
M, Grajkowska E, Mentges K, Boris L, Antony R, Garren N, Siegel C,
Lollo N, Cordova C, Aboud O, Theeler BJ, Burton EM, Penas-Prado M,
Leeper H, Gonzales J, Armstrong TS, Calvo KR, Figg WD, Kuhns DB,
Gallin JI, Gilbert MR.
Phase
I Study of Zotiraciclib in Combination with Temozolomide for
Patients with Recurrent High-grade Astrocytomas.
Clin
Cancer Res. 2021 Mar 30, 2021;27(12):3298-3306∟.
doi: 10.1158/1078-0432.CCR-20-4730∟.
PMID: 33785481∟.
Interventional study. ˍ
Pellerin
A, Khalifé M, Sanson M, Rozenblum-Beddok L, Bertaux M,
Soret M, Galanaud D, Dormont D, Kas A, Pyatigorskaya
N.
Simultaneously
acquired PET and ASL imaging biomarkers may be helpful in
differentiating progression from pseudo-progression in treated
gliomas.
Eur
Radiol. 2021 Mar 31∟.
doi: 10.1007/s00330-021-07732-0∟.
PMID: 33787971∟.
Observational study. ˍ
Tomoto
K, Fujimoto A, Inenaga C, Okanishi T, Imai S, Ogai M, Fukunaga A,
Nakamura H, Sato K, Obana A, Masui T, Arai Y, Enoki H.
Experience
using mTOR inhibitors for subependymal giant cell astrocytoma in
tuberous sclerosis complex at a single facility.
BMC
Neurol. 2021 Mar 31, 2021;21(1):139∟.
doi: 10.1186/s12883-021-02160-5∟.
PMID: 33784976∟.
Observational study. ˍ